Test Price
2,800 AED✅ Home Collection Available
PRKAG2 Gene Glycogen Storage Disease of Heart (Lethal) Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO‑Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post‑Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This next‑generation sequencing assay detects pathogenic variants in the PRKAG2 gene responsible for lethal glycogen storage cardiomyopathy, enabling definitive diagnosis, family screening, and clinical management. The assay covers the full coding region and intronic flanks, with Sanger confirmation for all reported variants.
| Feature | Our Test (NGS Technology) | Closest Alternative (Single‑Gene Sanger) |
|---|---|---|
| Precision | Full coding region ± intronic flanks; VUS resolution | Limited to targeted exonic regions only |
| Method | NGS + Sanger confirmation | Sanger sequencing of select exons |
| Turnaround | 3 to 4 Weeks | 4 to 6 Weeks |
Physician Insight & Safety Protocols
"As a clinical geneticist, I emphasize that a positive PRKAG2 variant confirms a high‑risk cardiac phenotype, yet it must be interpreted alongside echocardiography and family history. This test empowers timely, life‑saving surveillance, but results should never replace clinical judgement." — Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
🛡️ Exclusion Criteria & ER Red Flags
- Exclusion: Inability to provide a valid blood/DNA sample, lack of informed consent, or patients under 18 without legal guardian presence.
- Exclusion: Recent allogeneic blood transfusion may confound germline DNA results; postpone until 4 weeks post‑transfusion.
- Emergency Red Flag: This is a diagnostic and prognostic genetic test. Acute chest pain, syncope, or cardiac arrest require immediate emergency care – do not wait for genetic results.
Patient FAQ & Clinical Guidance
1. What is the PRKAG2 genetic test and why is it important for my heart?
The PRKAG2 genetic test analyzes a specific gene that, when mutated, causes a dangerous buildup of glycogen in heart muscle, leading to a potentially fatal cardiomyopathy. This test confirms the diagnosis, guides implantable defibrillator decisions, and enables testing of at‑risk relatives before symptoms appear.
2. How is the test performed and what is the turnaround time?
A small blood sample (or one drop on an FTA card) is collected by certified phlebotomists, either in‑clinic or through our premium home collection service (8 AM–11 PM). Results are delivered in 3 to 4 weeks, including a comprehensive clinical report and optional tele‑guidance.
3. Does insurance cover the cost, and how can I verify directly?
Many UAE insurers cover genetic testing for lethal cardiac glycogen storage disease when medically indicated; our billing team verifies coverage instantly via WhatsApp at +971 54 548 8731. We also offer transparent self‑pay packages at 2800 AED with no hidden fees.
UAE Regulatory & Data Privacy Adherence
UAE Regulatory Compliance
- Data Protection: Adherence to Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL).
- Health Data Security: Compliance with Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Clinical Safety & Consent: Guided by Federal Decree‑Law No. 4 of 2016 on Medical Liability.
- Quality Certification: ISO 9001:2015 Certified (Cert. No. INT/EGQ/2509DA/3139).
- DHA Facility License: 1143.
Clinical & Logistical Metadata
| Test Name | PRKAG2 Gene Glycogen Storage Disease of Heart (Lethal) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | Whole Blood (EDTA), Extracted DNA, or FTA Card |
| Methodology Used | Next‑Generation Sequencing (NGS) + Sanger Confirmation |
| ICD-10-CM Code | Z13.71 (Encounter for genetic testing for cardiovascular disease) |
| LOINC Code | 48758-1 (PRKAG2 gene targeted mutation analysis) |
| DHA Facility License & Laboratory Address | License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians